Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 6 studies | 24% ± 4% | |
endothelial cell | 5 studies | 34% ± 8% | |
epithelial cell | 3 studies | 29% ± 10% |
Insufficient scRNA-seq data for expression of SLC19A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1616.64 | 2630 / 2642 | 99% | 7.19 | 700 / 705 |
breast | 100% | 1128.25 | 458 / 459 | 98% | 8.56 | 1099 / 1118 |
lung | 100% | 2630.59 | 578 / 578 | 97% | 7.62 | 1126 / 1155 |
prostate | 98% | 1239.93 | 239 / 245 | 100% | 16.25 | 501 / 502 |
bladder | 100% | 823.95 | 21 / 21 | 97% | 9.73 | 490 / 504 |
ovary | 100% | 2293.35 | 180 / 180 | 97% | 6.99 | 415 / 430 |
intestine | 100% | 1125.02 | 963 / 966 | 96% | 10.43 | 508 / 527 |
skin | 96% | 914.06 | 1745 / 1809 | 99% | 13.80 | 466 / 472 |
stomach | 99% | 953.12 | 355 / 359 | 96% | 9.77 | 275 / 286 |
liver | 100% | 1992.50 | 226 / 226 | 94% | 8.15 | 382 / 406 |
uterus | 100% | 1325.15 | 170 / 170 | 89% | 6.88 | 410 / 459 |
pancreas | 99% | 744.52 | 325 / 328 | 89% | 4.62 | 158 / 178 |
esophagus | 90% | 576.34 | 1296 / 1445 | 96% | 6.70 | 176 / 183 |
kidney | 100% | 1316.42 | 89 / 89 | 84% | 3.95 | 756 / 901 |
adrenal gland | 100% | 1605.36 | 258 / 258 | 65% | 2.56 | 149 / 230 |
thymus | 100% | 2365.31 | 651 / 653 | 59% | 3.53 | 358 / 605 |
eye | 0% | 0 | 0 / 0 | 100% | 24.18 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.71 | 29 / 29 |
spleen | 100% | 2701.20 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.56 | 1 / 1 |
adipose | 100% | 1274.42 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 5301.26 | 923 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1506.07 | 1315 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 5.08 | 41 / 45 |
heart | 81% | 490.48 | 694 / 861 | 0% | 0 | 0 / 0 |
muscle | 35% | 138.61 | 279 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006855 | Biological process | xenobiotic transmembrane transport |
GO_0098656 | Biological process | monoatomic anion transmembrane transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0141111 | Biological process | positive regulation of cGAS/STING signaling pathway |
GO_0007565 | Biological process | female pregnancy |
GO_0051958 | Biological process | methotrexate transport |
GO_0140361 | Biological process | cyclic-GMP-AMP transmembrane import across plasma membrane |
GO_1904447 | Biological process | folate import across plasma membrane |
GO_0046655 | Biological process | folic acid metabolic process |
GO_0098838 | Biological process | folate transmembrane transport |
GO_0015711 | Biological process | organic anion transport |
GO_0015884 | Biological process | folic acid transport |
GO_0031526 | Cellular component | brush border membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0008514 | Molecular function | organic anion transmembrane transporter activity |
GO_0015297 | Molecular function | antiporter activity |
GO_0015350 | Molecular function | methotrexate transmembrane transporter activity |
GO_0042910 | Molecular function | xenobiotic transmembrane transporter activity |
GO_0061507 | Molecular function | 2',3'-cyclic GMP-AMP binding |
GO_0008517 | Molecular function | folic acid transmembrane transporter activity |
GO_0005542 | Molecular function | folic acid binding |
GO_0140360 | Molecular function | cyclic-GMP-AMP transmembrane transporter activity |
GO_0008518 | Molecular function | folate:monoatomic anion antiporter activity |
Gene name | SLC19A1 |
Protein name | SLC19A1 protein Solute carrier family 19 member 1 Reduced folate transporter (Solute carrier family 19 member 1) Reduced folate transporter (FOLT) (Cyclic dinucleotide:anion antiporter SLC19A1) (Folate:anion antiporter SLC19A1) (Intestinal folate carrier 1) (IFC-1) (Placental folate transporter) (Reduced folate carrier protein) (RFC) (hRFC) (Reduced folate transporter 1) (RFT-1) (Solute carrier family 19 member 1) (hSLC19A1) |
Synonyms | FLOT1 RFC1 |
Description | FUNCTION: Antiporter that mediates the import of reduced folates or a subset of cyclic dinucleotides, driven by the export of organic anions . Mechanistically, acts as a secondary active transporter, which exports intracellular organic anions down their concentration gradients to facilitate the uptake of its substrates . Has high affinity for N5-methyltetrahydrofolate, the predominant circulating form of folate . Also able to mediate the import of antifolate drug methotrexate . Also acts as an importer of immunoreactive cyclic dinucleotides, such as cyclic GMP-AMP (2'-3'-cGAMP), an immune messenger produced in response to DNA virus in the cytosol, and its linkage isomer 3'-3'-cGAMP, thus playing a role in triggering larger immune responses . 5-amino-4-imidazolecarboxamide riboside (AICAR), when phosphorylated to AICAR monophosphate, can serve as an organic anion for antiporter activity . . FUNCTION: Transporter that mediates the import of reduced folates. . |
Accessions | ENST00000380010.8 [P41440-3] ENST00000528477.1 H3BTQ3 A2VCN1 ENST00000427839.5 P41440 ENST00000485649.3 [P41440-2] C9J8K6 C9JKP4 ENST00000443742.1 ENST00000311124.9 [P41440-1] E9PIL5 ENST00000650808.1 [P41440-3] H0Y4T2 ENST00000567670.5 ENST00000417954.5 |